InvestorsHub Logo
Followers 69
Posts 11418
Boards Moderated 0
Alias Born 04/27/2012

Re: ernie44 post# 15571

Tuesday, 01/17/2017 11:33:31 AM

Tuesday, January 17, 2017 11:33:31 AM

Post# of 18784
Shares of the company, which engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health, are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $4.71 is greater than its 50-day moving average of $4.70. Get free access to your research report on AEZS at: http://www.activewallst.com/registration-3/?symbol=AEZS

(*L*)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News